Following the technology appraisal committee meeting on 14 December 2023, stakeholders are reminded that access to treatments will continue while the appraisal is ongoing. This will be the case for people starting the treatments as well as those already taking the treatments.
NICE has determined with key stakeholders that additional steps are required. We are pausing publication of final draft guidance after the second committee meeting to allow further discussions. The earliest anticipated date of final guidance publication will be updated once timelines are confirmed. Further details can be found here: https://www.nice.org.uk/guidance/gid-ta11187/documents/supporting-documentation-3